兴齐眼药 (300573)

Shenyang Xingqi Pharmaceutical Co., Ltd.

ASZ

Tags

Chemical PharmaceuticalsGuozheng Growth IndexSmall Cap GrowthHigh-Performing StocksChiNext 200 IndexChiNext InnovationChiNext Large CapChiNext 50 IndexChiNext IndexChiNext HealthcareSZSE 300 IndexSZSE Growth IndexPharma & BiotechSZSE Defensive 50 IndexStable Growth IndexCNI Private Placement IndexSZSE Medicine Equal Weight IndexPharmaceutical IndexShenzhen A-Share Pharmaceutical IndexChiNext Equal Weight IndexCS High Dividend Yield IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexSZSE 700 IndexSZSE Emerging Industries IndexSSE 700 Growth IndexZhongchuang Growth IndexSZSE 1000 IndexSZSE 300 Return IndexCSI 1000 Growth IndexSZSE Component Index ReturnCNI 1000 IndexXingyin Wealth Management Balanced 300 IndexSZSE Performance IndexGrowth 40 IndexChiNext Value IndexJuly 2022 Lock-up ExpiryInsurance Heavy HoldingsSmall-cap High Beta IndexSZSE Responsibility IndexCNI Responsibility IndexTechnology 50 Strategy IndexCS High-end Manufacturing IndexSME Board Innovation IndexChiNext Quality IndexSZSE High Beta IndexSZSE ChiNext 100 IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI IndexCSI 1000 IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexCCTV 500 IndexChiNext Basic IndexCS Pharmaceutical Innovation IndexChina United Quality Growth IndexSZSE Component Pharmaceutical IndexPharmaceutical Sub-sector IndexCSI All-share Pharmaceutical IndexSZSE Pharmaceutical 50 IndexSZSE 300 Equal Weight IndexChiNext Low Volatility IndexCSI 500 Equal Weight IndexCSI 800 Pharmaceutical IndexSZSE Component Index Equal WeightPharmaceutical & Health 100 IndexHigh Dividend Yield Strategy IndexCSI 700 IndexMid-small Cap IndexCSI 500 IndexPharmaceutical 50 IndexZhongchuang High Beta IndexCSI 500 Growth Innovation IndexPharmaceutical 50 Strategy IndexCSI 1000 Growth Innovation IndexSZSE 200 Return IndexSZSE 200 IndexCICC 300 IndexZhongchuang 400 IndexChiNext Growth IndexESG 300 IndexOrient Securities Competition IndexChiNext Return IndexSZSE 500 IndexChiNext Emerging IndexCSI 500 ESG IndexChiNext Growth IndexPerformance IndexLiaoning

K-Line Chart

No K-line data available

Company NameShenyang Xingqi Ophthalmic Pharmaceutical Co., Ltd.
Listing Date2016-12-08
Issue Price5.16RMB
Registered Capital24534.894510k RMB
Legal RepresentativeLiu Jidong
Registered AddressNo. 25, Xinyunhe Road, Hunnan District, Shenyang City, Liaoning Province
IndustryChemical Pharmaceuticals
Main BusinessA specialized enterprise engaged in the research and development, production, and sales of ophthalmic drugs.
Company ProfileShenyang Xingqi Ophthalmic Pharmaceutical Co., Ltd. is a national-level Torch high-tech enterprise specializing in the research and development, production, and sales of ophthalmic drugs. For over thirty years since its establishment, adhering to the corporate philosophy of 'Managing Health, Creating Brightness,' the company has dedicated itself to the human eye health industry with a spirit of 'Focus, Dedication, and Professionalism.' Currently, the company possesses eight major series comprising fifteen key products, including antibacterial drugs, anti-inflammatory drugs, artificial tears, corneal repair drugs, anti-fatigue drugs, mydriatics, surgical medications, and dry eye treatment drugs, providing high-quality products for the field of ophthalmic disease treatment.

Stock Details

1. Key Indicators

  • Total Shares(W): 24642.95
  • Circulating A-Shares(W): 18953.13
  • Earnings Per Share(RMB): 2.4400
  • Net Assets Per Share(RMB): 7.5700
  • Operating Revenue(W RMB): 190372.88
  • Total Profit(W RMB): 68877.09
  • Net Profit Attributable to Parent(W RMB): 59890.64
  • Net Profit Growth Rate(%): 105.98
  • Weighted Return on Equity(%): 32.9100
  • Operating Cash Flow Per Share(RMB): 2.3420
  • Undistributed Profit Per Share(RMB): 2.9170
  • Capital Reserve Per Share(RMB): 3.2958

2. Main Business

The main business covers:

  • Ophthalmic drug research and development
  • Ophthalmic drug production
  • Ophthalmic drug sales

3. Company Basic Information

  • Company Name: Shenyang Xingqi Pharmaceutical Co., Ltd.
  • Listing Date: 2016-12-08
  • Industry: Pharmaceutical Manufacturing
  • Address: 30F, Block B, Enterprise Plaza, No.125 Qingnian Street, Shenhe District, Shenyang City, Liaoning Province
  • Website: www.sinqi.com
  • Company Profile: Xingqi Eye Medicine was established as a joint stock company through the overall change of Xingqi Co., Ltd.'s audited net assets as of August 31, 2011. On October 28, 2011, the Foreign Trade and Economic Cooperation Bureau of Shenyang Economic and Technological Development Zone issued the "Approval on the Increase of Capital and Conversion of Shenyang Xingqi Pharmaceutical Co., Ltd. into a Foreign-invested Joint Stock Company and Renaming". On November 28, 2011, the company completed the industrial and commercial change registration at the Shenyang Administration for Industry and Commerce and obtained the "Business License of Legal Person" with registration number 210100401000628, with a registered capital of RMB 60 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hong Kong Securities Clearing Company Ltd. Northbound Capital 712.64 3.78
2 CSI 500 ETF Fund 250.63 1.33
3 China Life Insurance Company Limited - Traditional - General Insurance Product - 005L-CT001 Hu General Legal Person 63.43 0.34
4 Nuode Quality Consumption 6-month Holding Hybrid Securities Investment Fund Fund 11.90 0.06
5 Huashang Innovation Medical Care Hybrid Securities Investment Fund Class A Fund 3.31 0.02
6 Zheshang Huijin Emerging Consumption Flexible Allocation Hybrid Securities Investment Fund Fund 1.09 0.01
7 China Merchants Guozheng 2000 Index Enhanced Securities Investment Fund Class A Fund 0.83 0.00
8 Invesco Great Wall Guozheng 2000 Index Enhanced Securities Investment Fund Class A Fund 0.57 0.00
9 ChinaAMC ChiNext ETF Feeder Fund Class A Fund 0.01 0.00

5. Concept Sectors

  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High-performing Stocks
  • Small-cap Growth
  • SZSE Growth
  • ChiNext 300
  • SZSE Innovation
  • ChiNext Innovation
  • ChiNext Growth
  • ChiNext Quality
  • ChiNext Pharmaceuticals
  • ChiNext 200

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information